These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 15670771)

  • 1. Stable siRNA-mediated silencing of antizyme inhibitor: regulation of ornithine decarboxylase activity.
    Choi KS; Suh YH; Kim WH; Lee TH; Jung MH
    Biochem Biophys Res Commun; 2005 Mar; 328(1):206-12. PubMed ID: 15670771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cell proliferation by the antizyme inhibitor: evidence for an antizyme-independent mechanism.
    Kim SW; Mangold U; Waghorne C; Mobascher A; Shantz L; Banyard J; Zetter BR
    J Cell Sci; 2006 Jun; 119(Pt 12):2583-91. PubMed ID: 16735445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression.
    Nilsson J; Grahn B; Heby O
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):699-704. PubMed ID: 10698696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of antizyme-inhibitor in NIH3T3 fibroblasts provides growth advantage through neutralization of antizyme functions.
    Keren-Paz A; Bercovich Z; Porat Z; Erez O; Brener O; Kahana C
    Oncogene; 2006 Aug; 25(37):5163-72. PubMed ID: 16568078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
    Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S
    Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cellular polyamine levels and cellular proliferation by antizyme and antizyme inhibitor.
    Kahana C
    Essays Biochem; 2009 Nov; 46():47-61. PubMed ID: 20095969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antizyme inhibitor: a defective ornithine decarboxylase or a physiological regulator of polyamine biosynthesis and cellular proliferation.
    Keren-Paz A; Bercovich Z; Kahana C
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):311-3. PubMed ID: 17371267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of all members of the antizyme family by antizyme inhibitor.
    Mangold U; Leberer E
    Biochem J; 2005 Jan; 385(Pt 1):21-8. PubMed ID: 15355308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear translocation of antizyme and expression of ornithine decarboxylase and antizyme are developmentally regulated.
    Gritli-Linde A; Nilsson J; Bohlooly-Y M; Heby O; Linde A
    Dev Dyn; 2001 Mar; 220(3):259-75. PubMed ID: 11241834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding.
    Almrud JJ; Oliveira MA; Kern AD; Grishin NV; Phillips MA; Hackert ML
    J Mol Biol; 2000 Jan; 295(1):7-16. PubMed ID: 10623504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antizyme 3 inhibits polyamine uptake and ornithine decarboxylase (ODC) activity, but does not stimulate ODC degradation.
    Snapir Z; Keren-Paz A; Bercovich Z; Kahana C
    Biochem J; 2009 Apr; 419(1):99-103, 1 p following 103. PubMed ID: 19076071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docking of antizyme to ornithine decarboxylase and antizyme inhibitor using experimental mutant and double-mutant cycle data.
    Cohavi O; Tobi D; Schreiber G
    J Mol Biol; 2009 Jul; 390(3):503-15. PubMed ID: 19465028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antizyme family for regulating polyamines.
    Kahana C
    J Biol Chem; 2018 Nov; 293(48):18730-18735. PubMed ID: 30355739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ODCp, a brain- and testis-specific ornithine decarboxylase paralogue, functions as an antizyme inhibitor, although less efficiently than AzI1.
    Snapir Z; Keren-Paz A; Bercovich Z; Kahana C
    Biochem J; 2008 Mar; 410(3):613-9. PubMed ID: 18062773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
    Hurta RA; Lee J; Voskas D
    J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental alterations in expression and subcellular localization of antizyme and antizyme inhibitor and their functional importance in the murine mammary gland.
    Murakami Y; Suzuki J; Samejima K; Oka T
    Amino Acids; 2010 Feb; 38(2):591-601. PubMed ID: 19997757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human ornithine decarboxylase paralogue (ODCp) is an antizyme inhibitor but not an arginine decarboxylase.
    Kanerva K; Mäkitie LT; Pelander A; Heiskala M; Andersson LC
    Biochem J; 2008 Jan; 409(1):187-92. PubMed ID: 17900240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of ornithine decarboxylase by the 26S proteasome.
    Murakami Y; Matsufuji S; Hayashi S; Tanahashi N; Tanaka K
    Biochem Biophys Res Commun; 2000 Jan; 267(1):1-6. PubMed ID: 10623564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
    Voskas D; Mader R; Lee J; Hurta RA
    Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a novel human ornithine decarboxylase-like protein in the central nervous system and testes.
    Pitkänen LT; Heiskala M; Andersson LC
    Biochem Biophys Res Commun; 2001 Oct; 287(5):1051-7. PubMed ID: 11587527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.